RxDoctor Payments Data

Rami Payman, MD

Otology & Neurotology · Poughkeepsie, NYNPI 1134239445

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.

$3,748in general payments, 2019–2025

Across 144 payments — averaging $26.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$785
  • GSK$715
  • Somnomed Inc.$463
  • Acclarent, Inc$366
  • Regeneron Healthcare Solutions, Inc.$313
  • Optinose US, Inc.$246
  • plus $858 from 17 others

What the payments were for

  • Food & beverage$3,71499%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,748 in reported general payments places this provider in the 60th percentile of 26 otology & neurotology providers in New York.

See all otology & neurotology providers in New York

Medicare billing

Part B allowed, 2024
$174,462
Medicare patients
612
Services billed
1,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth50$5,673
Azelastine Hcl195$3,980
Famotidine194$3,080
Fluocinolone Acetonide Oil42$2,004
Ipratropium Bromide92$2,002
Fluticasone Propionate98$1,773
Omeprazole78$863
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort15$834
Pantoprazole Sodium95$824
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid51$528
Meclizine Hcl39$372
Prednisone22$156
Amitriptyline Hcl35$141
Methylprednisolone13$99
Mupirocin20$93

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →